These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 377005)

  • 1. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly.
    Davidson MB
    Metabolism; 1979 Jun; 28(6):688-705. PubMed ID: 377005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate metabolism and insulin resistance in myotonia dystrophica.
    Tevaarwerk GJ; Hudson AJ
    J Clin Endocrinol Metab; 1977 Mar; 44(3):491-8. PubMed ID: 320224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
    Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
    Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
    Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
    Bigelow-Sherman JD; Shima K; Borden EK; Foà PP; Penhallegon R
    Acta Diabetol Lat; 1970; 7(1):68-92. PubMed ID: 5493440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of islet-cell function in man.
    Arky RA; Knopp RH
    N Engl J Med; 1971 Nov; 285(20):1130-1. PubMed ID: 4937863
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?
    Scheen AJ
    Diabetes Metab; 2005 Dec; 31 Spec No 2():5S27-5S34. PubMed ID: 16415763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carbohydrate metabolism in liver diseases].
    Mosin VI
    Klin Med (Mosk); 1974 Feb; 52(2):. PubMed ID: 4619410
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between carbohydrate tolerance, insulin secretion, and insulin sensitivity of isolated fat cells from obese protodiabetics.
    Schulz B; Knospe S; Michaelis D; Titze K; Hildmann W
    Acta Diabetol Lat; 1978; 15(3-4):166-74. PubMed ID: 360750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and non-esterified fatty acid metabolism in asymptomatic diabetics and atherosclerotic subjects.
    Kashyap ML; Magill F; Rojas L; Hoffman MM
    Can Med Assoc J; 1970 May; 102(11):1165-9. PubMed ID: 5420996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
    Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carbohydrate metabolic changes in cystic fibrosis].
    García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
    Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
    Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Mari A; DeFronzo RA
    J Clin Endocrinol Metab; 2005 Jan; 90(1):493-500. PubMed ID: 15483086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward an integrated phenotype in pre-NIDDM.
    Bergman RN; Watanabe R; Rebrin K; Ader M; Steil G
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S67-77. PubMed ID: 8894486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A method of studying insulin secretion in humans: the glucose stimulation test, followed by tolbutamide].
    Vague P; Ramahandridona G; Vialettes B
    Nouv Presse Med; 1976 Dec; 5(4):3001-4. PubMed ID: 794823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.
    Kautzky-Willer A; Prager R; Waldhausl W; Pacini G; Thomaseth K; Wagner OF; Ulm M; Streli C; Ludvik B
    Diabetes Care; 1997 Nov; 20(11):1717-23. PubMed ID: 9353615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiological and clinical aspects of circadian variations in glucose tolerance.
    Wojtczak-Jaroszowa J
    Chronobiologia; 1977; 4(4):363-84. PubMed ID: 350522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of therapy on glucose and lipid metabolism as well as insulin secretion in diabetes mellitus].
    Lohmann D; Verlohren HJ; Pohl A; Brückner U
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(2):77-84. PubMed ID: 1017406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.